pmc logo image
Logo of jclinpathJournal of Clinical PathologyCurrent TOCInstructions for authors

Formats:

J Clin Pathol. 1987 March; 40(3): 245–246.
PMCID: PMC1140891
Incidence and clinical importance of bone marrow eosinophilia in Hodgkin's disease (BNLI Report No 29). British National Lymphoma Investigation.
E A Macintyre, B Vaughan Hudson, G Vaughan Hudson, A M Jelliffe, and D C Linch
Abstract
A retrospective study of 136 bone marrow aspirates was undertaken before treatment to evaluate the importance of bone marrow eosinophilia in Hodgkin's disease. This occurred in 28 patients (21%) but did not correlate with age, sex, B symptoms, histopathological type or peripheral blood count. It also had no effect on survival. Bone marrow eosinophilia, therefore, seems to represent a common but non-specific reaction to Hodgkin's disease.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (260K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
 
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Bennett MH, Tu A, Hudson GV. Analysis of grade 1 Hodgkin's disease (Report no 6). Clin Radiol. 1981 Sep;32(5):491–498. [PubMed]
  • Kass L, Votaw ML. Eosinophilia and plasmacytosis of the bone marrow in Hodgkin's disease. Am J Clin Pathol. 1975 Aug;64(2):248–250. [PubMed]